cobas 5800 is a new compact addition to the Roche molecular diagnostics portfolio that provides a scalable, high performance testing solution for labs of all sizes. Infectious diseases, such as HIV, ...

Molecular testing, or molecular diagnostics, refers to a group of tests that look at the genetic material in a specimen. It can detect genetic risk factors for certain diseases or provide evidence of ...

A recent blood-based hepatitis C virus assay on Nuclein's DASH system highlighted its on-device sample prep, among other features that have been driving its adoption.

High Efficiency means low-cost, easy-to-use molecular testing under $20 per test with no sample preparation required. 3EO announces the availability of no charge ...

The Eonis™ Q system from Revvity is an innovative dry PCR workflow that simplifies and streamlines molecular testing for SMA and SCID. It comprises the compact Eonis™ Q96 instrument, stable and ...

LOS ANGELES--(BUSINESS WIRE)--Molecular Instruments® (MI), founded by the inventor of the HCR™ technology, today announces the upcoming release of the HCR™ HiFi Encoder, a breakthrough advance in ...

A panelist discusses how education and cost are key challenges in ensuring comprehensive molecular testing is performed in a timely manner for patients with ovarian cancer, emphasizing the need for ...

Dublin, Sept. 13, 2017 (GLOBE NEWSWIRE) -- The "China Molecular Diagnostics Market, Test Volume & Forecast: by Oncology Test (Breast Cancer, Colorectal Cancer, and Prostate Cancer) Infectious Disease ...

Advancing next-generation IMC workflows with class-leading HCR imaging technologies for greater sensitivity and flexibility The partnership combines HCR Gold for RNA and protein imaging with the ...

The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma We conducted a real-world cohort study ...

Molecular Instruments, Inc. announced today that the Unified Patent Court (UPC) of the European Union has found that Molecular Instruments’ HCR™ RNA-ISH technology does not infringe two patents owned ...